Bone Therapeutics SA (BOTHE):製薬・医療:M&Aディール及び事業提携情報

GlobalDataが発行した調査報告書(DATA904C8198)
◆英語タイトル:Bone Therapeutics SA (BOTHE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8198
◆発行会社(リサーチ会社):GlobalData
◆発行日:2018年10月
◆ページ数:45
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:ベルギー
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥26,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥52,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥78,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
Bone Therapeutics SA (Bone Therapeutics) is a cell therapy company that develops autologous and allogeneic cell therapy products. The company offers pipeline products such as PREOB, an autologous osteoblastic cell therapy product used for the treatment of osteonecrosis and non-union fractures; and ALLOB, an allogeneic osteoblastic cell therapy product, for delayed-union fractures, spinal fusion procedures, and frevision spinal fusion. Bone Therapeutics conducts preclinical research on next generation product candidates such as combined cell-matrix products for large bone defects and maxillofacial applications. The company conducts clinical studies for treatment of delayed-union fractures and spinal fusion. Bone Therapeutics is headquartered in Gosselies, Belgium.

Bone Therapeutics SA (BOTHE) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Bone Therapeutics SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Bone Therapeutics SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Bone Therapeutics SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Bone Therapeutics SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Bone Therapeutics SA, Medical Devices Deals, 2012 to YTD 2018 10
Bone Therapeutics SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Bone Therapeutics SA, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Bone Therapeutics Raises US$8 Million In Series D Financing Round 12
Partnerships 13
Bone Therapeutics to Enter into Agreement with Cellthera Pharm 13
Bone Therapeutics Extends Agreement with Kasios 14
Licensing Agreements 15
Asahi Kasei Enters into Licensing Agreement with Bone Therapeutics 15
Bone Therapeutics Enters into Licensing Agreement with Enrico Bastianelli 16
Enrico Bastianelli Enters into Licensing Agreement with Bone Therapeutics 17
Bone Therapeutics Enters into Licensing Agreement with Enrico Bastianelli for BONE-011 18
Equity Offering 19
Bone Therapeutics Withdraws Private Placement of Shares 19
Bone Therapeutics Raises USD38 Million in IPO 21
Debt Offering 23
Bone Therapeutics Raises USD24.1 Million in Private Placement of Bonds 23
Bone Therapeutics SA – Key Competitors 24
Bone Therapeutics SA – Key Employees 25
Bone Therapeutics SA – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Recent Developments 27
Financial Announcements 27
Aug 30, 2018: Bone Therapeutics announces H1 results for 2018 27
Apr 25, 2018: Bone Therapeutics Announces Full Year 2017 Financial Results 28
Nov 09, 2017: Bone Therapeutics: Business Update for Third Quarter 2017 29
Aug 31, 2017: Bone Therapeutics Announces H1 Results for 2017 30
May 11, 2017: Bone Therapeutics Business Update for First Quarter 2017 32
Mar 16, 2017: Bone Therapeutics Reports Full Year 2016 Results 33
Jan 17, 2017: Bone Therapeutics Provides Business Update for Q4 2016 34
Corporate Communications 36
Jun 14, 2018: Bone Therapeutics announces results of Annual General Meeting 36
Apr 26, 2018: Bone Therapeutics Appoints Claudia D’Augusta As Non-Executive Director 37
Feb 20, 2018: Bone Therapeutics strengthens Board with the appointment of Jean Stephenne as Chairman 38
Aug 31, 2017: Bone Therapeutics Appoints Jean-Luc Vandebroek as Chief Financial Officer 39
Jul 03, 2017: Bone Therapeutics Strengthens Board of Directors 40
May 29, 2017: Bone Therapeutics: Strengthens Board with the appointments of Steve Swinson and Damian Marron as Non-Executive Directors 42
Mar 06, 2017: Bone Therapeutics Strengthens Clinical Development Leadership with Appointment of Dr. Miguel Forte as Chief Medical Officer 43
Other Significant Developments 44
Jan 23, 2018: Bone Therapeutics provides business outlook and announces its financial calendar for 2018 44
Appendix 45
Methodology 45
About GlobalData 45
Contact Us 45
Disclaimer 45

List of Tables
Bone Therapeutics SA, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Bone Therapeutics SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Bone Therapeutics SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Bone Therapeutics SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Bone Therapeutics SA, Deals By Therapy Area, 2012 to YTD 2018 9
Bone Therapeutics SA, Medical Devices Deals, 2012 to YTD 2018 10
Bone Therapeutics SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Bone Therapeutics Raises US$8 Million In Series D Financing Round 12
Bone Therapeutics to Enter into Agreement with Cellthera Pharm 13
Bone Therapeutics Extends Agreement with Kasios 14
Asahi Kasei Enters into Licensing Agreement with Bone Therapeutics 15
Bone Therapeutics Enters into Licensing Agreement with Enrico Bastianelli 16
Enrico Bastianelli Enters into Licensing Agreement with Bone Therapeutics 17
Bone Therapeutics Enters into Licensing Agreement with Enrico Bastianelli for BONE-011 18
Bone Therapeutics Withdraws Private Placement of Shares 19
Bone Therapeutics Raises USD38 Million in IPO 21
Bone Therapeutics Raises USD24.1 Million in Private Placement of Bonds 23
Bone Therapeutics SA, Key Competitors 24
Bone Therapeutics SA, Key Employees 25
Bone Therapeutics SA, Subsidiaries 26

List of Figures
Bone Therapeutics SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Bone Therapeutics SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Bone Therapeutics SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Bone Therapeutics SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Bone Therapeutics SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Bone Therapeutics SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Bone Therapeutics SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Bone Therapeutics SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Bone Therapeutics SA, Medical Devices Deals, 2012 to YTD 2018 10

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Bone Therapeutics SA (BOTHE):製薬・医療:M&Aディール及び事業提携情報(Bone Therapeutics SA (BOTHE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆